SOX9 and central nervous system cancer: In gliomas, SOX9 has been shown to maintain the self-renewal ability of GSCs.70 GBM cells transfected with shRNA-mediated linc00174 knockdown are associated with increased miR-138-5p and decreased SOX9 levels.